Mateon Therapeutics Inc Common Stock
Why Robinhood?
You can watch MATN and buy or sell other stocks, ETFs, and their options commission-free!About MATN
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
MATN Key Statistics
Stock Snapshot
Mateon Therapeutics Inc Common Stock(MATN) stock is priced at $0.26, giving the company a market capitalization of 115.49M. It carries a P/E multiple of 0.11.
On 2026-05-27, Mateon Therapeutics Inc Common Stock(MATN) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 365.98K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.11.
The stock's 52-week range extends from a low of $0.02 to a high of $0.11.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.